ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,976Medicare Part D Prescriptions Filled, Including Refills

Rank: 331 out of 5176

$899K Total Retail Price of All Prescriptions

Rank: 347 out of 5176

401 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 401 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 12,401 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SYNTHROID 531 498 1 33
SIMVASTATIN 492 466 2 1
AMLODIPINE BESYLATE 412 404 3 2
GLIMEPIRIDE 371 344 4 37
ZOLPIDEM TARTRATE 346 327 5 17
ENALAPRIL MALEATE 317 282 6 22
ATENOLOL 307 299 7 12
LEVOTHYROXINE SODIUM 305 268 8 4
FUROSEMIDE 297 293 9 8
METFORMIN HCL 285 269 10 7
NEXIUM 248 245 11 16
ATORVASTATIN CALCIUM 243 237 12 9
OMEPRAZOLE 240 227 13 3
METOPROLOL SUCCINATE 207 198 14 11
PLAVIX 197 197 15 29
POTASSIUM CHLORIDE 190 190 16 34
CLOPIDOGREL 180 180 17 26
LANTUS SOLOSTAR 175 142 18 70
ACARBOSE 174 174 19 223
TAMSULOSIN HCL 154 154 20 20
CLOTRIMAZOLE-BETAMETHASONE 153 151 21 94
CRESTOR 149 146 22 15
JANUVIA 134 133 23 25
LOSARTAN POTASSIUM 133 133 24 14
ALENDRONATE SODIUM 130 117 25 18
RAMIPRIL 127 122 26 50
CIPROFLOXACIN HCL 121 109 27 84
ISOSORBIDE MONONITRATE ER 116 116 28 44
ALCOHOL SWABS 106 100 29 115
CARVEDILOL 103 103 30 24
LIPITOR 102 102 31 51
NIFEDIPINE ER 100 100 32 48
NOVOLOG FLEXPEN 100 86 32 196
LANTUS 99 99 34 66
INSULIN SYRINGE 99 99 34 137
BENICAR 97 97 36 100
NAMENDA 97 97 36 47
GABAPENTIN 93 93 38 21
ALLOPURINOL 89 89 39 41
NITROGLYCERIN PATCH 85 85 40 149
CLONIDINE HCL 82 81 41 79
LIDODERM 80 80 42 59
QUINAPRIL HCL 79 79 43 82
DONEPEZIL HCL 78 78 44 28
FINASTERIDE 78 78 44 69
MELOXICAM 77 77 46 53
ACETAMINOPHEN-CODEINE 76 74 S3 47 127
ZETIA 74 68 48 68
ACTOS 73 65 49 85
GLYBURIDE-METFORMIN HCL 72 72 R 50 76
METOPROLOL TARTRATE 72 66 50 6
LOVAZA 72 66 50 43
DIOVAN 69 69 53 19
CITALOPRAM HBR 68 68 54 31
PEN NEEDLE 68 59 54 144
DIGOXIN 66 66 56 56
ADVAIR DISKUS 65 52 57 32
LEVEMIR FLEXPEN 63 63 58 200
MECLIZINE HCL 60 60 59 81
SINGLE USE SWAB 60 59 59 108
UNIFINE PENTIPS 58 52 61 261
LISINOPRIL 57 56 62 5
TERAZOSIN HCL 57 57 62 158
ESCITALOPRAM OXALATE 55 55 64 89
RANITIDINE HCL 54 54 65 36
HYDRALAZINE HCL 53 45 66 73
CELEBREX 53 53 66 80
EVISTA 51 51 68 65
PROAIR HFA 50 50 69 60
COUMADIN 50 50 69 112
SERTRALINE HCL 50 50 69 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.